Anticoagulants Current Events | Anticoagulants News
|
|
|
Sort By:
Page Views | Date |
Women may stop anticoagulants after blood clots
Women may safely discontinue oral anticoagulants (blood thinners) after 6 months of treatment following a first unprovoked venous blood clot (thromboembolism) if they have no or one risk factor. view more (2008-08-26)
Are blood thinners post-op killers?
New study shows that the use of powerful anticoagulants to prevent pulmonary embolism may actually lead to more deaths after surgery view more (2008-04-01)
Safety of antithrombotic treatment in acute coronary syndromes
The management of acute coronary syndromes (with or without ST segment elevation) requires the use of anticoagulants, antiplatelet agents (aspirin, clopidogrel and/or glycoprotein (GP) IIb/IIIa inhibitors), beta-blockers, thrombolytics in some cases, and revascularization / reperfusion. view more (2008-09-03)
ESC Congress 2004: Fishy stuff or a real cure? - Contrary to popular belief, a Danish study now suggests that consumption of fish does not prevent atrial fibrillation
Danish scientists from the University Hospital in Aarhus have carried out a study that questions the effect of consuming n-3 fatty acids from fish on the prevention of atrial fibrillation. Atrial fibrillation is an irregularity of the heart rhythm that - if left untreated - may lead to stroke and death. Atrial fibrillation is most often treated... view more... (2004-08-31)
Comparison of anticoagulants for angioplasty show similar outcomes
In a comparison of anticoagulants and stents for use with angioplasty following a heart attack, the anticoagulants abciximab and tirofiban had similar outcomes for some cardiac measures within 90 minutes after the procedure, while patients who received stents that released the drug sirolimus had a lower risk of major adverse cardiac events within... view more... (2008-03-31)
Curacyte awarded a EUR1.2M grant to fund development of Factor Xa inhibitors
Curacyte AG, a Munich-based drug development company, has announced that its wholly owned subsidiary, Curacyte Chemistry GmbH based in Jena, has been awarded a EUR1.2M R&D grant from the German State of Thuringia's Corporate Technology Development Program. The grant will fund the lead optimization and pre-clinical development of the Company's... view more... (2003-10-29)
Computers pass dosage test for thrombosis drugs
The largest ever study into the administration of blood thinning drugs like Warfarin has concluded that dosages calculated by computer are at least as safe and reliable as those provided by trained medical professionals. view more (2007-07-20)
Computers as safe as medical experts for prescribing blood thinning drugs
The largest ever study into the administration of blood thinning drugs, principally Warfarin, has concluded that dosages calculated by computer are at least as safe and reliable as those provided by expert medical professionals. view more (2008-06-19)
Misclassified for centuries, medicinal leeches found to be 3 distinct species
Genetic research has revealed that commercially available medicinal leeches used around the world in biomedical research and postoperative care have been misclassified for centuries. view more (2007-04-12)
Is it reasonable to perform polypectomy without interruption of anticoagulation?
Currently, patients taking anticoagulants to prevent stroke and blood clots are often recommended to stop these medications in order to perform colonoscopy with removal of polyps. view more (2009-05-08)
Rising rates of bleeding from ulcers in last decade despite changes in treatment
Hospital admissions for bleeding ulcers rose throughout the 1990s despite changes in drug treatment, reveals a study in Gut. view more (2002-03-11)
Dabigatran vs. warfarin as long-term anticoagulant therapy in atrial fibrillation
The anticoagulant dabigatran is more effective than warfarin in the prevention of stroke in patients with atrial fibrillation, according to results from the RE-LY study (Randomized Evaluation of Long-term anticoagulant therapY). view more (2009-08-31)
Image-guided treatment for deep venous thrombosis could improve patients' long-term outcomes
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term... view more... (2009-09-21)
Carotid artery surgery could substantially reduce stroke among high-risk patients (pp 1486, 1491)
Results of an international study in this week's issue of THE LANCET suggest that surgery to widen narrowed carotid arteries could halve the risk of stroke among high-risk patients. However, authors of the study caution that surgery carries its own stroke risks if not done by experts. There is currently debate as to whether people who have... view more... (2004-05-05)
Kidney disease increases the risk of stroke in patients
Chronic kidney disease increases the risk of stroke in patients with atrial fibrillation (AF), the most common type of heart arrhythmia, according to a new study by Kaiser Permanente researchers in the current online issue of Circulation. view more (2009-03-05)
Mayo researchers explore reasons for complications with kidney failure patients
Mayo Clinic researchers searching for explanations of high mortality rates among kidney failure patients undergoing hemodialysis are focusing their attention on the use of heparin, a drug used to reduce clotting of the blood. view more (2005-08-18)
Fish oil prevents potentially deadly decline in heart rate variability
A two-gram fish oil supplement given daily to elderly persons prevented a decline in heart rate variability caused by tiny, dangerous airborne pollutant particles. view more (2005-12-16)
Common blood thinner increases risk of bone fracture
Elderly patients taking the commonly prescribed blood thinner warfarin experience an increased risk for osteoporosis-linked bone fractures, according to a study at Washington University School of Medicine in St. Louis. view more (2006-01-24)
Part of drug trial for patients with atrial fibrillation discontinued
Study treatments for the ACTIVE W trial of the ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) program have been discontinued due to a significant difference in efficacy, in favour of the standard oral anticoagulation (OAC) over antiplatelet therapy (clopidogrel plus aspirin). view more (2005-09-07)
Researchers design model for automated, wearable artificial kidney
Two researchers from UCLA and the Veterans Affairs Greater Los Angeles Healthcare System have developed a design for an automated, wearable artificial kidney, or AWAK, that avoids the complications patients often suffer with traditional dialysis. view more (2008-07-11)
|
|
|
|
Sort By:
Page Views | Date |
|
